Authors,Title,Year,Source title,Volume,Issue,Art. No.,Page start,Page end,Page count,Cited by,DOI,Link,Document Type,Source,EID
"Duong, J.K., Kroonen, M.Y.A.M., Kumar, S.S., Heerspink, H.L., Kirkpatrick, C.M., Graham, G.G., Williams, K.M., Day, R.O.","A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function",2017,"European Journal of Clinical Pharmacology","73","8",,"981","990",,,10.1007/s00228-017-2251-1,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018253948&doi=10.1007%2fs00228-017-2251-1&partnerID=40&md5=3a0eb7f0d686700d8c09f88dd6d8ec8d",Article,Scopus,2-s2.0-85018253948
"Kamel, B., Graham, G.G., Williams, K.M., Pile, K.D., Day, R.O.","Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat",2017,"Clinical Pharmacokinetics","56","5",,"459","475",,,10.1007/s40262-016-0466-4,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991688611&doi=10.1007%2fs40262-016-0466-4&partnerID=40&md5=0866b63bee7fe35ec029b72d94a0c1cc",Article,Scopus,2-s2.0-84991688611
"Kannangara, D.R.W., Graham, G.G., Wright, D.F.B., Stocker, S.L., Portek, I., Pile, K.D., Barclay, M.L., Williams, K.M., Stamp, L.K., Day, R.O.","Individualising the dose of allopurinol in patients with gout",2017,"British Journal of Clinical Pharmacology",,,,"","",,,10.1111/bcp.13307,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019737982&doi=10.1111%2fbcp.13307&partnerID=40&md5=a0411f6c1bbd95c4e1355344e57fd463",Article in Press,Scopus,2-s2.0-85019737982
"Moon, J., Kumar, S.S., Graham, G.G., Baysari, M.T., Williams, K.M., Chen, W., Viardot, A., Greenfield, J.R., Day, R.O.","Trends in metformin utilisation and dose appropriateness in Australia",2016,"European Journal of Clinical Pharmacology","72","12",,"1489","1496",,1,10.1007/s00228-016-2117-y,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84983740610&doi=10.1007%2fs00228-016-2117-y&partnerID=40&md5=ebe967f8f1564c5074b180267ebae2b6",Article,Scopus,2-s2.0-84983740610
"Smith, F.C., Kumar, S.S., Furlong, T.J., Gangaram, S.V., Greenfield, J.R., Stocker, S.L., Graham, G.G., Williams, K.M., Day, R.O.","Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration",2016,"American Journal of Kidney Diseases","68","6",,"990","992",,,10.1053/j.ajkd.2016.08.017,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991199712&doi=10.1053%2fj.ajkd.2016.08.017&partnerID=40&md5=876f575dbf414fd3843d4b6bb7cb4d02",Letter,Scopus,2-s2.0-84991199712
"Kannangara, D.R.W., Graham, G.G., Williams, K.M., Day, R.O.","Effect of xanthine oxidase inhibitors on the renal clearance of uric acid and creatinine",2016,"Clinical Rheumatology","35","9",,"2375","2376",,2,10.1007/s10067-015-3165-x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84953410137&doi=10.1007%2fs10067-015-3165-x&partnerID=40&md5=50d5960f2c787873ee865538a66901c1",Letter,Scopus,2-s2.0-84953410137
"Kannangara, D.R.W., Phipps-Green, A.J., Dalbeth, N., Stamp, L.K., Williams, K.M., Graham, G.G., Day, R.O., Merriman, T.R.","Hyperuricaemia: Contributions of urate transporter ABCG2 and the fractional renal clearance of urate",2016,"Annals of the Rheumatic Diseases","75","7",,"1363","1366",,3,10.1136/annrheumdis-2015-208111,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954290224&doi=10.1136%2fannrheumdis-2015-208111&partnerID=40&md5=6557ae79512995dba0d1233d46e24dc0",Article,Scopus,2-s2.0-84954290224
"Day, R.O., Kamel, B., Kannangara, D.R.W., Williams, K.M., Graham, G.G.","Xanthine oxidoreductase and its inhibitors: Relevance for gout",2016,"Clinical Science","130","23",,"2167","2180",,1,10.1042/CS20160010,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014377473&doi=10.1042%2fCS20160010&partnerID=40&md5=42912f46b273c78e4b7a47f3966400cb",Review,Scopus,2-s2.0-85014377473
"Martinello, M., Schteinman, A., Alavi, M., Williams, K., Dore, G.J., Day, R., Matthews, G.V.","The impact of ribavirin plasma concentration on the eficacy of the interferon-sparing regimen, sofosbuvir and ribavirin",2016,"Antiviral Therapy","21","2",,"127","132",,1,10.3851/IMP2984,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84975113581&doi=10.3851%2fIMP2984&partnerID=40&md5=49a86a736c4a3f76a6bcab9479b21aff",Article,Scopus,2-s2.0-84975113581
"Vaccher, S., Kannangara, D.R.W., Baysari, M.T., Reath, J., Zwar, N., Williams, K.M., Day, R.O.","Barriers to care in gout: From prescriber to patient",2016,"Journal of Rheumatology","43","1",,"144","149",,3,10.3899/jrheum.150607,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85011890863&doi=10.3899%2fjrheum.150607&partnerID=40&md5=82554e1362d0ca7002104890a07c8ca0",Article,Scopus,2-s2.0-85011890863
"Rasheed, H., McKinney, C., Stamp, L.K., Dalbeth, N., Topless, R.K., Day, R., Kannangara, D., Williams, K., Smith, M., Janssen, M., Jansen, T.L., Joosten, L.A., Radstake, T.R., Riches, P.L., Tausche, A.-K., Lioté, F., Lu, L., Stahl, E.A., Choi, H.K., So, A., Merriman, T.R.","The toll-like receptor 4 (TLR4) variant rs2149356 and risk of gout in European and polynesian sample sets",2016,"PLoS ONE","11","1", e0147939,"","",,5,10.1371/journal.pone.0147939,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959203555&doi=10.1371%2fjournal.pone.0147939&partnerID=40&md5=e5c6f63d331149399c1b3cdc48be1de9",Article,Scopus,2-s2.0-84959203555
"Chung, W.-H., Chang, W.-C., Stocker, S.L., Juo, C.-G., Graham, G.G., Lee, M.-H.H., Williams, K.M., Tian, Y.-C., Juan, K.-C., Wu, Y.-J.J., Yang, C.-H., Chang, C.-J., Lin, Y.-J., Day, R.O., Hung, S.-I.","Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: The impact of renal insufficiency, high plasma levels of oxypurinol and granulysin",2015,"Annals of the Rheumatic Diseases","74","12",,"2157","2164",,30,10.1136/annrheumdis-2014-205577,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84952990733&doi=10.1136%2fannrheumdis-2014-205577&partnerID=40&md5=e2a84018c9dec9c6326efb5ad98512f4",Article,Scopus,2-s2.0-84952990733
"McKinney, C., Stamp, L.K., Dalbeth, N., Topless, R.K., Day, R.O., Kannangara, D.R.W., Williams, K.M., Janssen, M., Jansen, T.L., Joosten, L.A., Radstake, T.R., Riches, P.L., Tausche, A.-K., Lioté, F., So, A., Merriman, T.R.","Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout",2015,"Arthritis Research and Therapy","17","1", 288,"","",,10,10.1186/s13075-015-0802-3,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955375751&doi=10.1186%2fs13075-015-0802-3&partnerID=40&md5=5e8dee730a6f369c811c06fb8a2b902a",Article,Scopus,2-s2.0-84955375751
"Hmar, R.C., Kannangara, D.R.W., Ramasamy, S.N., Baysari, M.T., Williams, K.M., Day, R.O.","Understanding and improving the use of allopurinol in a teaching hospital",2015,"Internal Medicine Journal","45","4",,"383","390",,,10.1111/imj.12701,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964240699&doi=10.1111%2fimj.12701&partnerID=40&md5=84e416edefce3e56fc5f776237dcf0f6",Article,Scopus,2-s2.0-84964240699
"Ghosh, D., Williams, K.M., Graham, G.G., Nair, P., Buscher, H., Day, R.O.","Multiple episodes of aspirin overdose in an individual patient: A case report",2014,"Journal of Medical Case Reports","8","1", 374,"","",,,10.1186/1752-1947-8-374,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964316085&doi=10.1186%2f1752-1947-8-374&partnerID=40&md5=4a1c308fbec2272330a3a5cac68885b4",Article,Scopus,2-s2.0-84964316085
"Kannangara, D.R.W., Graham, G.G., Williams, K.M., Day, R.O.","Hypouricemic effects of prednisone and allopurinol: An uneven playing field?",2014,"Canadian Journal of Cardiology","30","3",,"","",,1,10.1016/j.cjca.2013.04.015,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84894251564&doi=10.1016%2fj.cjca.2013.04.015&partnerID=40&md5=314bec70f7b40a05d7990ee1480ddc4a",Letter,Scopus,2-s2.0-84894251564
"Kannangara, D.R.W., Ramasamy, S.N., Ray, J.E., Jones, G., Graham, G.G., Williams, K.M., Day, R.O.","An audit of a therapeutic drug monitoring service for allopurinol therapy",2013,"Therapeutic Drug Monitoring","35","6",,"863","866",,,10.1097/FTD.0b013e318299920a,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84889260354&doi=10.1097%2fFTD.0b013e318299920a&partnerID=40&md5=38c574ee3f38cc5f5a917bc6d450fcbe",Article,Scopus,2-s2.0-84889260354
"Graham, G.G., Kannangara, D.R.W., Stocker, S.L., Portek, I., Pile, K.D., Indraratna, P.L., Datta, I., Williams, K.M., Day, R.O.","Understanding the dose-response relationship of allopurinol: Predicting the optimal dosage",2013,"British Journal of Clinical Pharmacology","76","6",,"932","938",,14,10.1111/bcp.12126,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888028037&doi=10.1111%2fbcp.12126&partnerID=40&md5=6e6a2cfe46668d63756dcaa9cc4ef8d9",Article,Scopus,2-s2.0-84888028037
"Ramasamy, S.N., Korb-Wells, C.S., Kannangara, D.R.W., Smith, M.W.H., Wang, N., Roberts, D.M., Graham, G.G., Williams, K.M., Day, R.O.","Allopurinol hypersensitivity: A systematic review of all published cases, 1950-2012",2013,"Drug Safety","36","10",,"953","980",,59,10.1007/s40264-013-0084-0,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84885110998&doi=10.1007%2fs40264-013-0084-0&partnerID=40&md5=62977296931cca8a849583e08bcf2922",Review,Scopus,2-s2.0-84885110998
"Day, R., Lee, H., Graham, G., Williams, K.","Benzbromarone: Availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt on benzbromarone)",2013,"New Zealand Medical Journal","126","1382",,"124","126",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884540462&partnerID=40&md5=66f533efad8f4c5b9364ff6b31f800bd",Letter,Scopus,2-s2.0-84884540462
"Duong, J.K., Furlong, T.J., Roberts, D.M., Graham, G.G., Greenfield, J.R., Williams, K.M., Day, R.O.","The role of metformin in metformin-associated lactic acidosis (MALA): Case series and formulation of a model of pathogenesis",2013,"Drug Safety","36","9",,"733","746",,26,10.1007/s40264-013-0038-6,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890210243&doi=10.1007%2fs40264-013-0038-6&partnerID=40&md5=b6d455373a607a1b81fd7ec04fd07d82",Article,Scopus,2-s2.0-84890210243
"Day, R.O., Williams, K.M., Graham, G.G.","Urate-lowering therapy: Uricosurics",2013,"Gout",,,,"174","189",,2,10.2217/EBO.13.104,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937413674&doi=10.2217%2fEBO.13.104&partnerID=40&md5=64e30a0a56863e595f0f2a67dcc234a3",Book Chapter,Scopus,2-s2.0-84937413674
"Wong, C., Kumar, S.S., Graham, G.G., Begg, E.J., Chin, P.K.L., Brett, J., Ray, J.E., Marriott, D.J.E., Williams, K.M., Day, R.O.","Comparing dose prediction software used to manage gentamicin dosing",2013,"Internal Medicine Journal","43","5",,"519","525",,6,10.1111/imj.12067,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877886428&doi=10.1111%2fimj.12067&partnerID=40&md5=a8f022664bd11a85c02c075f0cc71b78",Article,Scopus,2-s2.0-84877886428
"Duong, J.K., Kumar, S.S., Kirkpatrick, C.M., Greenup, L.C., Arora, M., Lee, T.C., Timmins, P., Graham, G.G., Furlong, T.J., Greenfield, J.R., Williams, K.M., Day, R.O.","Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: Simulation of doses according to renal function",2013,"Clinical Pharmacokinetics","52","5",,"373","384",,48,10.1007/s40262-013-0046-9,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84886992019&doi=10.1007%2fs40262-013-0046-9&partnerID=40&md5=d25b3fb7ca2324b489baae5adc80b1c7",Article,Scopus,2-s2.0-84886992019
"Brett, J., Chong, O., Graham, G.G., Ray, J.E., Marriott, D., Williams, K.M., Day, R.O.","Antifungal use and therapeutic monitoring of plasma concentrations of itraconazole in heart and lung transplantation patients",2013,"Therapeutic Drug Monitoring","35","1",,"133","136",,7,10.1097/FTD.0b013e318275fe69,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872863022&doi=10.1097%2fFTD.0b013e318275fe69&partnerID=40&md5=56c394683d7b0c6ee09740ee58da557c",Article,Scopus,2-s2.0-84872863022
"Lee, M.-H.H., Stocker, S.L., Williams, K.M., Day, R.O.","HLA-B*5801 should be used to screen for risk of Stevens-Johnson syndrome in family members of Han Chinese patients commencing allopurinol therapy",2013,"Journal of Rheumatology","40","1",,"96","97",,7,10.3899/jrheum.120803,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871880477&doi=10.3899%2fjrheum.120803&partnerID=40&md5=bd90e65d1ffcc00d5fced27f3a3f3bcd",Letter,Scopus,2-s2.0-84871880477
"Duong, J.K., Roberts, D.M., Furlong, T.J., Kumar, S.S., Greenfield, J.R., Kirkpatrick, C.M., Graham, G.G., Williams, K.M., Day, R.O.","Metformin therapy in patients with chronic kidney disease",2012,"Diabetes, Obesity and Metabolism","14","10",,"963","965",,31,10.1111/j.1463-1326.2012.01617.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865998218&doi=10.1111%2fj.1463-1326.2012.01617.x&partnerID=40&md5=6d3697fca1540925d8359cc477f954c9",Letter,Scopus,2-s2.0-84865998218
"Stocker, S.L., Mclachlan, A.J., Savic, R.M., Kirkpatrick, C.M., Graham, G.G., Williams, K.M., Day, R.O.","The pharmacokinetics of oxypurinol in people with gout",2012,"British Journal of Clinical Pharmacology","74","3",,"477","489",,12,10.1111/j.1365-2125.2012.04207.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864809757&doi=10.1111%2fj.1365-2125.2012.04207.x&partnerID=40&md5=f931458564ceb8663cbef85920ee3767",Article,Scopus,2-s2.0-84864809757
"Kannangara, D.R.W., Ramasamy, S.N., Indraratna, P.L., Stocker, S.L., Graham, G.G., Jones, G., Portek, I., Williams, K.M., Day, R.O.","Fractional clearance of urate: Validation of measurement in spot-urine samples in healthy subjects and gouty patients",2012,"Arthritis Research and Therapy","14","4", R189,"","",,10,10.1186/ar4020,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84869111149&doi=10.1186%2far4020&partnerID=40&md5=f79f3bee2fb35918ec6d635ba8076ad4",Article,Scopus,2-s2.0-84869111149
"Kannangara, D.R.W., Roberts, D.M., Furlong, T.J., Graham, G.G., Williams, K.M., Day, R.O.","Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease",2012,"British Journal of Clinical Pharmacology","73","5",,"828","829",,2,10.1111/j.1365-2125.2011.04147.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859414534&doi=10.1111%2fj.1365-2125.2011.04147.x&partnerID=40&md5=68f92706f254f739df14e5f2d54cff62",Letter,Scopus,2-s2.0-84859414534
"Lee, M.H., Stocker, S.L., Anderson, J., Phillips, E.J., Nolan, D., Williams, K.M., Graham, G.G., Sullivan, J.R., Day, R.O.","Initiating allopurinol therapy: Do we need to know the patient's human leucocyte antigen status?",2012,"Internal Medicine Journal","42","4",,"411","416",,30,10.1111/j.1445-5994.2011.02567.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859835143&doi=10.1111%2fj.1445-5994.2011.02567.x&partnerID=40&md5=079bd4eb608902a4815ea8702f4b8623",Article,Scopus,2-s2.0-84859835143
"Milder, T.Y., Lipworth, W.L., Williams, K.M., Ritchie, J.E., Day, R.O.","""It looks after me"": How older patients make decisions about analgesics for osteoarthritis",2011,"Arthritis Care and Research","63","9",,"1280","1286",,14,10.1002/acr.20514,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052288227&doi=10.1002%2facr.20514&partnerID=40&md5=de44f41fed4fe07de1e89829fd8c3afa",Article,Scopus,2-s2.0-80052288227
"Ng, D.Y., Stocker, S.L., Graham, G.G., Williams, K.M., Day, R.O.","Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers",2011,"European Journal of Clinical Pharmacology","67","7",,"709","713",,1,10.1007/s00228-010-0963-6,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959688948&doi=10.1007%2fs00228-010-0963-6&partnerID=40&md5=3969eb719e72864aa2cbb4b6be74e24a",Article,Scopus,2-s2.0-79959688948
"Stocker, S.L., Graham, G.G., McLachlan, A.J., Williams, K.M., Day, R.O.","Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout",2011,"Journal of Rheumatology","38","5",,"904","910",,28,10.3899/jrheum.101160,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955565930&doi=10.3899%2fjrheum.101160&partnerID=40&md5=7bfb19763f5067ec8cd6be9bf2e4a17d",Article,Scopus,2-s2.0-79955565930
"Wang, N., Lipworth, W.L., Ritchie, J.E., Williams, K.M., Day, R.O.","Eliciting views of Australian pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines",2011,"Internal Medicine Journal","41","4",,"314","320",,2,10.1111/j.1445-5994.2010.02239.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-79954991027&doi=10.1111%2fj.1445-5994.2010.02239.x&partnerID=40&md5=167e8c65baa0caf1d4249f41abfd213b",Article,Scopus,2-s2.0-79954991027
"Milder, T.Y., Williams, K.M., Ritchie, J.E., Lipworth, W.L., Day, R.O.","Use of NSAIDs for osteoarthritis amongst older-aged primary care patients: Engagement with information and perceptions of risk",2011,"Age and Ageing","40","2", afq160,"254","259",,16,10.1093/ageing/afq160,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-79951801968&doi=10.1093%2fageing%2fafq160&partnerID=40&md5=42a62b827a00953d67b3c30344ae266c",Article,Scopus,2-s2.0-79951801968
"Graham, G.G., Punt, J., Arora, M., Day, R.O., Doogue, M.P., Duong, J.K., Furlong, T.J., Greenfield, J.R., Greenup, L.C., Kirkpatrick, C.M., Ray, J.E., Timmins, P., Williams, K.M.","Clinical pharmacokinetics of metformin",2011,"Clinical Pharmacokinetics","50","2",,"81","98",,340,10.2165/11534750-000000000-00000,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-78751500357&doi=10.2165%2f11534750-000000000-00000&partnerID=40&md5=3a124920c70d858929435d0fae260cc2",Review,Scopus,2-s2.0-78751500357
"Indraratna, P.L., Stocker, S.L., Williams, K.M., Graham, G.G., Jones, G., Day, R.O.","A proposal for identifying the low renal uric acid clearance phenotype",2010,"Arthritis Research and Therapy","12","6", 149,"","",,6,10.1186/ar3191,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959267915&doi=10.1186%2far3191&partnerID=40&md5=6e5e09b2fe016e0eb6f064706210f041",Note,Scopus,2-s2.0-79959267915
"Stocker, S.L., Franklin, M.E., Anderson, J.M., Pillans, P.I., Williams, K.M., McLachlan, A.J., Day, R.O., Taylor, P.J.","Measurement of urinary oxypurinol by high performance liquid chromatography-tandem mass spectrometry",2010,"Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences","878","25",,"2363","2368",,7,10.1016/j.jchromb.2010.07.017,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955843370&doi=10.1016%2fj.jchromb.2010.07.017&partnerID=40&md5=e506eeed401df66b1af6ea32504860fb",Article,Scopus,2-s2.0-77955843370
"Day, R.O., Liauw, W., Tozer, L.M.R., McElduff, P., Beckett, R.J., Williams, K.M.","A double-blind, placebo-controlled study of the short term effects of a spring water supplemented with magnesium bicarbonate on acid/base balance, bone metabolism and cardiovascular risk factors in postmenopausal women",2010,"BMC Research Notes","3",, 180,"","",,8,10.1186/1756-0500-3-180,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955002107&doi=10.1186%2f1756-0500-3-180&partnerID=40&md5=4c78fda364b1f53f933145efd5ee32b0",Article,Scopus,2-s2.0-77955002107
"Palmer, H., Graham, G., Williams, K., Day, R.","A Risk-Benefit Assessment of Paracetamol (Acetaminophen) Combined with Caffeine",2010,"Pain Medicine","11","6",,"951","965",,15,10.1111/j.1526-4637.2010.00867.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954452496&doi=10.1111%2fj.1526-4637.2010.00867.x&partnerID=40&md5=06e895526b65bc3872608c0ca8b3be3a",Article,Scopus,2-s2.0-77954452496
"Abdul, M.I.M., Jiang, X., Williams, K.M., Day, R.O., Roufogalis, B.D., Liauw, W.S., Xu, H., Matthias, A., Lehmann, R.P., McLachlan, A.J.","Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects",2010,"British Journal of Clinical Pharmacology","69","5",,"508","515",,21,10.1111/j.1365-2125.2010.03620.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950641040&doi=10.1111%2fj.1365-2125.2010.03620.x&partnerID=40&md5=51d53f6e1149764dc7fa1f766bdcae74",Article,Scopus,2-s2.0-77950641040
"Indraratna, P.L., Williams, K.M., Graham, G.G., Day, R.O.","Hyperuricemia, cardiovascular disease, and the metabolic syndrome",2009,"Journal of Rheumatology","36","12",,"2842","2843",,8,10.3899/jrheum.090500,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-72449208160&doi=10.3899%2fjrheum.090500&partnerID=40&md5=b77453246d1448047f86479a40ff8b35",Letter,Scopus,2-s2.0-72449208160
"Pett, S.L., McCarthy, M.C., Cooper, D.A., MacRae, K., Tendolkar, A., Norris, R., Strizki, J.M., Williams, K.M., Emery, S.","A phase I study to explore the activity and safety of SCH532706, a small molecular chemokine receptor-5 antagonist in HIV type-1-infected patients",2009,"Antiviral Therapy","14","1",,"111","115",,14,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-61849179239&partnerID=40&md5=83ae9a4f5e78bbbb2d649efacb9575fc",Article,Scopus,2-s2.0-61849179239
"Burrell, C., Booy, R., Wood, N., Egan, A.-M., Taverner, D., Williams, K., Liauw, W., Moskwa, A., Pepin-Covatta, S., Saville, M.","Immunogenicity of a reduced dose of A/H3N2 in the 2005 southern hemisphere formulation of inactivated split influenza vaccine",2008,"Influenza and other Respiratory Viruses","2","3",,"93","98",,,10.1111/j.1750-2659.2008.00039.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-64949164916&doi=10.1111%2fj.1750-2659.2008.00039.x&partnerID=40&md5=d96618b82d21c2f7aba6c2333c457063",Article,Scopus,2-s2.0-64949164916
"Mohammed Abdul, M.I., Jiang, X., Williams, K.M., Day, R.O., Roufogalis, B.D., Liauw, W.S., Xu, H., McLachlan, A.J.","Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects",2008,"British Journal of Pharmacology","154","8",,"1691","1700",,73,10.1038/bjp.2008.210,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-49449094988&doi=10.1038%2fbjp.2008.210&partnerID=40&md5=cadb53754017aedd192a148f0ecdc0a8",Article,Scopus,2-s2.0-49449094988
"Lee, M.-H.H., Graham, G.G., Williams, K.M., Day, R.O.","A benefit-risk assessment of benzbromarone in the treatment of gout: Was its withdrawal from the market in the best interest of patients?",2008,"Drug Safety","31","8",,"643","665",,103,10.2165/00002018-200831080-00002,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-47649130363&doi=10.2165%2f00002018-200831080-00002&partnerID=40&md5=0b45be75f1939ce9fc707423bfac3c9b",Review,Scopus,2-s2.0-47649130363
"Lu, C.Y., Macneill, P., Williams, K., Day, R.","Access to high cost medicines in Australia: Ethical perspectives",2008,"Australia and New Zealand Health Policy","5",, 4,"","",,6,10.1186/1743-8462-5-4,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-44949144929&doi=10.1186%2f1743-8462-5-4&partnerID=40&md5=bd92060bd98db991ce77ba2e9522b9e6",Article,Scopus,2-s2.0-44949144929
"McLachlan, A., Day, R., Williams, K., Graham, G., Stocker, S.","Maximising gout therapy",2008,"Australian Journal of Pharmacy","89","1057",,"86","88",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-43949139594&partnerID=40&md5=7ba211f3d40b9b4057db2f1ee0ef1f9f",Short Survey,Scopus,2-s2.0-43949139594
"Lu, C.Y., Williams, K., Day, R.","Access to biologic medicines for the treatment of rheumatic diseases: Lessons from Australia",2008,"International Journal of Rheumatic Diseases","11","1",,"11","14",,2,10.1111/j.1756-185X.2008.00322.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-54949130661&doi=10.1111%2fj.1756-185X.2008.00322.x&partnerID=40&md5=4425d8a4763996c83e00844af6fefef2",Article,Scopus,2-s2.0-54949130661
"Xu, H., Williams, K.M., Liauw, W.S., Murray, M., Day, R.O., McLachlan, A.J.","Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide",2008,"British Journal of Pharmacology","153","7",,"1579","1586",,59,10.1038/sj.bjp.0707685,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-41649113326&doi=10.1038%2fsj.bjp.0707685&partnerID=40&md5=9da4358e43e77cfb999e73384532c696",Article,Scopus,2-s2.0-41649113326
"Stocker, S.L., Williams, K.M., McLachlan, A.J., Graham, G.G., Day, R.O.","Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects",2008,"Clinical Pharmacokinetics","47","2",,"111","118",,24,10.2165/00003088-200847020-00004,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-38149106573&doi=10.2165%2f00003088-200847020-00004&partnerID=40&md5=572f5c21cc3b1dae91ba297e4661faee",Article,Scopus,2-s2.0-38149106573
"Lu, C.Y., Ritchie, J., Williams, K., Day, R.","The views of stakeholders on controlled access schemes for high-cost antirheumatic biological medicines in Australia",2007,"Australia and New Zealand Health Policy","4","1", 26,"","",,4,10.1186/1743-8462-4-26,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-39049114515&doi=10.1186%2f1743-8462-4-26&partnerID=40&md5=f9e26c56e0ab141f804c211b0e344825",Article,Scopus,2-s2.0-39049114515
"Lu, C.Y., Williams, K.M., Day, R.O.","Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme?",2007,"Internal Medicine Journal","37","9",,"601","606",,7,10.1111/j.1445-5994.2007.01396.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-34547864986&doi=10.1111%2fj.1445-5994.2007.01396.x&partnerID=40&md5=5a1668effcb650e444015b407bf31868",Article,Scopus,2-s2.0-34547864986
"Day, R.O., Graham, G.G., Hicks, M., McLachlan, A.J., Stocker, S.L., Williams, K.M.","Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol",2007,"Clinical Pharmacokinetics","46","8",,"623","644",,79,10.2165/00003088-200746080-00001,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-34547621773&doi=10.2165%2f00003088-200746080-00001&partnerID=40&md5=49783351a6fec698ef360b4d6c9b0f5b",Review,Scopus,2-s2.0-34547621773
"Winston, A., Mallon, P.W.G., Satchell, C., MacRae, K., Williams, K.M., Schutz, M., Law, M., Cooper, D.A., Emery, S.","The safety, efficacy and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation",2007,"Clinical Infectious Diseases","44","11",,"1475","1483",,18,10.1086/517507,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-34249027965&doi=10.1086%2f517507&partnerID=40&md5=c917fef9fc55005cd8bd04ac45c4058a",Article,Scopus,2-s2.0-34249027965
"Day, R.O., Graham, G., Williams, K.","Fenofibratewarfarin interaction [1]",2007,"Australian Prescriber","30","2",,"32","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-34147109867&partnerID=40&md5=6325d0df5834b54e83aebdeeb9a753da",Letter,Scopus,2-s2.0-34147109867
"Lu, C.Y., Williams, K.M., Day, R.O.","The funding and use of high-cost medicines in Australia: The example of anti-rheumatic biological medicines",2007,"Australia and New Zealand Health Policy","4","1", 2,"","",,20,10.1186/1743-8462-4-2,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-38549133605&doi=10.1186%2f1743-8462-4-2&partnerID=40&md5=2f54c2f27ddc83550b7832c0339d0caa",Article,Scopus,2-s2.0-38549133605
"Day, R.O., Williams, K.M.","Open-label extension studies: Do they provide meaningful information on the safety of new drugs?",2007,"Drug Safety","30","2",,"93","105",,13,10.2165/00002018-200730020-00001,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846661265&doi=10.2165%2f00002018-200730020-00001&partnerID=40&md5=812561024c94c03a374b857778013ef8",Review,Scopus,2-s2.0-33846661265
"Loboz, K.K., Gross, A.S., Williams, K.M., Liauw, W.S., Day, R.O., Blievernicht, J.K., Zanger, U.M., McLachlan, A.J.","Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: Effect of induction by rifampin and ethnicity",2006,"Clinical Pharmacology and Therapeutics","80","1",,"75","84",,66,10.1016/j.clpt.2006.03.010,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745678731&doi=10.1016%2fj.clpt.2006.03.010&partnerID=40&md5=113febf441dac0b11049faa5bceeb178",Article,Scopus,2-s2.0-33745678731
"Lu, C.Y., Williams, K.M., Day, R.O.","Accessing health outcome data on high-cost medicines in Australia",2006,"Medical Journal of Australia","184","8",,"411","413",,7,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646244039&partnerID=40&md5=9be522fb043985ed4a8ab9e72ef757b3",Article,Scopus,2-s2.0-33646244039
"Lu, C.Y., Williams, K.M., Day, R.O.","Access to tumour necrosis factor inhibitors for rheumatoid arthritis treatment under the Australian Pharmaceutical Benefits Scheme: Are we on target?",2006,"Internal Medicine Journal","36","1",,"19","27",,9,10.1111/j.1445-5994.2005.00992.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644833351&doi=10.1111%2fj.1445-5994.2005.00992.x&partnerID=40&md5=0c94b12c556039fa59eba794d1d29294",Article,Scopus,2-s2.0-33644833351
"Ritchie, J., Lu, C., Williams, K., Day, R.","Sample size is beside the point in policy development research",2005,"Australian and New Zealand Journal of Public Health","29","6",,"583","",,2,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-28944450571&partnerID=40&md5=8004eddb44c28d4b87236c00cce6aacd",Article,Scopus,2-s2.0-28944450571
"Lu, C.Y., Ritchie, J., Williams, K.M., Day, R.O.","Recent developments in targeting access to high cost medicines in Australia",2005,"Australia and New Zealand Health Policy","2","1", 28,"","",,6,10.1186/1743-8462-2-28,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33845201146&doi=10.1186%2f1743-8462-2-28&partnerID=40&md5=afc97610e392799d5d96966d8487bf19",Article,Scopus,2-s2.0-33845201146
"Mallon, P.W.G., Unemori, P., Sedwell, R., Morey, A., Rafferty, M., Williams, K., Chisholm, D., Samaras, K., Emery, S., Kelleher, A., Cooper, D.A., Carr, A.","In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA",2005,"Journal of Infectious Diseases","191","10",,"1686","1696",,134,10.1086/429697,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-20844435624&doi=10.1086%2f429697&partnerID=40&md5=c1897c670a7757940b6e66663b87624d",Article,Scopus,2-s2.0-20844435624
"Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O., McLachlan, A.J.","Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects",2005,"British Journal of Clinical Pharmacology","59","4",,"425","432",,121,10.1111/j.1365-2125.2005.02322.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-17144396657&doi=10.1111%2fj.1365-2125.2005.02322.x&partnerID=40&md5=3d5969611c4e159b24036cd5eabb1687",Article,Scopus,2-s2.0-17144396657
"Lee, E.J., Williams, K., Day, R., Graham, G., Champion, D.","Stereoselective disposition of ibuprofen enantiomers in man. 1985.",2004,"British journal of clinical pharmacology","58","7",,"S759","764; discussion S765-767",,5,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-16644385820&partnerID=40&md5=7cc725d7c4b66e5c0cf775404eeb3403",Article,Scopus,2-s2.0-16644385820
"Lee, E.J.D., Williams, K., Day, R., Graham, G., Champion, D., Geisslinger, G.","Stereoselective disposition of ibuprofen enantiomers in man",2004,"British Journal of Clinical Pharmacology","58","7 SPEC. ISS.",,"S765","S767",,1,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-11144252325&partnerID=40&md5=2ed466f9bdb4fc986dcc0fb1e6b09aed",Note,Scopus,2-s2.0-11144252325
"Lu, C.Y., Williams, K.M., March, L., Bertouch, J.V., Day, R.O., Sansom, L.N.","Subsidised access to TNFα inhibitors: Is the rationale for exclusion of rheumatoid-factor-negative patients defensible? (multiple letters) [1]",2004,"Medical Journal of Australia","181","8",,"457","458",,6,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-7044247960&partnerID=40&md5=798c198ba52f7055800c697b402e0d3a",Letter,Scopus,2-s2.0-7044247960
"Lu, C.Y., Williams, K., Day, R., March, L., Sansom, L., Bertouch, J.","Access to high cost drugs in Australia",2004,"British Medical Journal","329","7463",,"415","416",,29,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-4344629209&partnerID=40&md5=956ca2eecffdc4d31e844b8bc36ee84f",Editorial,Scopus,2-s2.0-4344629209
"Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O., McLachlan, A.J.","Erratum: Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects (British Journal of Clinical Pharmacology (2004) 57 (592-599))",2004,"British Journal of Clinical Pharmacology","58","1",,"102","",,1,10.1111/j.1365-2125.2004.02155.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-3142556133&doi=10.1111%2fj.1365-2125.2004.02155.x&partnerID=40&md5=0ac605b1451c140dfd25589f6801bf6a",Erratum,Scopus,2-s2.0-3142556133
"Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O., McLachlan, A.J.","Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects",2004,"British Journal of Clinical Pharmacology","57","5",,"592","599",,163,10.1111/j.1365-2125.2003.02051.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-2342563067&doi=10.1111%2fj.1365-2125.2003.02051.x&partnerID=40&md5=d611d7df96e6600b2e7d4deb0a6e77c4",Article,Scopus,2-s2.0-2342563067
"Pett, S.L., Williams, L.A., Day, R.O., Lloyd, A.R., Carr, A.D., Clezy, K.R., Emery, S., Kaplan, E., McPhee, D.A., McLachlan, A.J., Gelder, F.B., Lewin, S.R., Liauw, W., Williams, K.M.","A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, PEHRG214, in HIV-1-infected individuals",2004,"HIV Clinical Trials","5","2",,"91","98",,7,10.1310/1FLN-8KFC-5HEQ-K19J,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-2542536738&doi=10.1310%2f1FLN-8KFC-5HEQ-K19J&partnerID=40&md5=fa0c0dd16898ce53edcb7dc860d0d16b",Article,Scopus,2-s2.0-2542536738
"Lomas, M., Liauw, W., Packham, D., Williams, K., Kelleher, A., Zaunders, J., Ward, R.","Phase I clinical trial of a human idiotypic p53 vaccine in patients with advanced malignancy",2004,"Annals of Oncology","15","2",,"324","329",,13,10.1093/annonc/mdh053,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-1342267590&doi=10.1093%2fannonc%2fmdh053&partnerID=40&md5=70247eebd809b13fcc5070c14f9fd312",Article,Scopus,2-s2.0-1342267590
"Sasongko, L., Williams, K.M., Day, R.O., McLachlan, A.J.","Human subcutaneous tissue distribution of fluconazole: Comparison of microdialysis and suction blister techniques",2003,"British Journal of Clinical Pharmacology","56","5",,"551","561",,21,10.1046/j.1365-2125.2003.01930.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0242575967&doi=10.1046%2fj.1365-2125.2003.01930.x&partnerID=40&md5=d0ff570244f93f0200f2d0e9227e7708",Article,Scopus,2-s2.0-0242575967
"Wren, B.G., Day, R.O., McLachlan, A.J., Williams, K.M.","Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal women",2003,"Climacteric","6","2",,"104","111",,9,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038131743&partnerID=40&md5=bd99fa4c0dcc49fe7a1181ff7eedadce",Article,Scopus,2-s2.0-0038131743
"Sasongko, L., Ramzan, I., Williams, K.M., McLachlan, A.J.","Muscle distribution of the neuromuscular blocker gallamine using microdialysis",2002,"Journal of Pharmaceutical Sciences","91","3",,"769","775",,4,10.1002/jps.10082,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036281182&doi=10.1002%2fjps.10082&partnerID=40&md5=0c1abe61e28699b02422eaa337683db8",Article,Scopus,2-s2.0-0036281182
"Williams, K.M., Cooper, S., Parisis, K., Handel, M., Day, R.O.","The skin suction blister: A human model of inflammation",2001,"Clinical Pharmacology and Therapeutics","69","2",,"","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33748982209&partnerID=40&md5=1cc1254232126b0375d1003c7d5a8832",Article,Scopus,2-s2.0-33748982209
"Campbell, T.J., Williams, K.M.","Therapeutic drug monitoring: Antiarrhythmic drugs",2001,"British Journal of Clinical Pharmacology","52","SUPPL. 1",,"21S","34S",,35,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034838866&partnerID=40&md5=ae1e4aac7a53577371b216253c795aae",Article,Scopus,2-s2.0-0034838866
"Sasongko, L., Ramzan, I., Williams, K.M., McLachlan, A.J.","Application of a high-performance liquid chromatographic assay for the neuromuscular blocker gallamine to analysis of rat plasma, muscle and microdialysate samples",2001,"Journal of Chromatography B: Biomedical Sciences and Applications","754","2",,"467","475",,4,10.1016/S0378-4347(01)00032-9,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035946739&doi=10.1016%2fS0378-4347%2801%2900032-9&partnerID=40&md5=2ff2527a8493983b6cf37a5ab25bfd0a",Article,Scopus,2-s2.0-0035946739
"Sasongko, L., Williams, K.M., Ramzan, I., McLachlan, A.J.","Assessment of in vitro and in vivo recovery of gallamine using microdialysis",2000,"Journal of Pharmacological and Toxicological Methods","44","3",,"519","525",,14,10.1016/S1056-8719(00)00117-9,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034442146&doi=10.1016%2fS1056-8719%2800%2900117-9&partnerID=40&md5=0dfad0aec503c265732b29bb6b371512",Article,Scopus,2-s2.0-0034442146
"Davies, N.M., McLachlan, A.J., Day, R.O., Williams, K.M.","Clinical pharmacokinetics and pharmacodynamics of celecoxib. A selective cyclo-oxygenase-2 inhibitor",2000,"Clinical Pharmacokinetics","38","3",,"225","242",,276,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034062275&partnerID=40&md5=106ab7bfd1a0bf138fe576804dc768ab",Review,Scopus,2-s2.0-0034062275
"Williams, K.M., Day, R.O., Roberts, L.K., Harbin, J.A.","A comparison of the efficacy of α-ketobutyric acid (KBA), nordihidro-guaiaretic acid (NDGA), salicylic acid (SA), and placebo (P) in the accelerated removal of corns",1999,"Clinical Pharmacology and Therapeutics","65","2",,"122","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749113393&partnerID=40&md5=e18ab442ac95fb94e7118c8744ff280f",Article,Scopus,2-s2.0-33749113393
"Day, R.O., McLachlan, A.J., Graham, G.G., Williams, K.M.","Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid",1999,"Clinical Pharmacokinetics","36","3",,"191","210",,62,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032896464&partnerID=40&md5=3460ddbfddb108c2affa6e81e7b1e4a8",Review,Scopus,2-s2.0-0032896464
"Browne, G.S., Nelson, C., Nguyen, T., Ellis, B.A., Day, R.O., Williams, K.M.","Stereoselective and substrate-dependent inhibition of hepatic mitochondrial β-oxidation and oxidative phosphorylation by the non-steroidal anti inflammatory drugs ibuprofen, flurbiprofen, and ketorolac",1999,"Biochemical Pharmacology","57","7",,"837","844",,22,10.1016/S0006-2952(98)00342-6,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033004051&doi=10.1016%2fS0006-2952%2898%2900342-6&partnerID=40&md5=076aa7b8ec5ad986dcdf88e34ddef62c",Article,Scopus,2-s2.0-0033004051
"Erb, K., Brugger, R., Williams, K., Geisslinger, G.","Stereoselective disposition of tiaprofenic acid enantiomers in rats",1999,"Chirality","11","2",,"103","108",,11,10.1002/(SICI)1520-636X(1999)11:2&lt;103::AID-CHIR4&gt;3.0.CO;2-1,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032897643&doi=10.1002%2f%28SICI%291520-636X%281999%2911%3a2%26lt%3b103%3a%3aAID-CHIR4%26gt%3b3.0.CO%3b2-1&partnerID=40&md5=7b379692b379d9ed1cffc9ea32f071f2",Article,Scopus,2-s2.0-0032897643
"Campbell, T.J., Williams, K.M.","Therapeutic drug monitoring: Antiarrhythmic drugs",1998,"British Journal of Clinical Pharmacology","46","4",,"307","319",,45,10.1046/j.1365-2125.1998.00768.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031690661&doi=10.1046%2fj.1365-2125.1998.00768.x&partnerID=40&md5=d70155b35a87da22dde78dc370b2fc36",Review,Scopus,2-s2.0-0031690661
"Scheuerer, S., Hall, S.D., Williams, K.M., Geisslinger, G.","Effect of clofibrate on the chiral inversion of ibuprofen in healthy volunteers",1998,"Clinical Pharmacology and Therapeutics","64","2",,"168","176",,12,10.1016/S0009-9236(98)90150-3,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031690584&doi=10.1016%2fS0009-9236%2898%2990150-3&partnerID=40&md5=f2f023cd4de111bce0825e479e74674c",Article,Scopus,2-s2.0-0031690584
"Day, R.O., Chalmers, D.R.C., Williams, K.M., Campbell, T.J.","The death of a healthy volunteer in a human research project: Implications for Australian clinical research",1998,"Medical Journal of Australia","168","9",,"449","451",,42,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032482243&partnerID=40&md5=8457609c1a0dfa9826c04ab6710d0645",Article,Scopus,2-s2.0-0032482243
"Scheuerer, S., Williams, K.M., Brugger, R., Mclachlan, A.J., Brune, K., Day, R.O., Geisslinger, G.","Effect of clofibrate on the chiral disposition of ibuprofen in rats",1998,"Journal of Pharmacology and Experimental Therapeutics","284","3",,"1132","1138",,9,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031885836&partnerID=40&md5=c451ad8bcc8dfc100cc447fdf438e661",Article,Scopus,2-s2.0-0031885836
"Wang, X., Liu, Y.-S., Nair, U.B., Armstrong, D.W., Ellis, B., Williams, K.M.","Enantiomeric composition of monoterpenes in conifer resins",1997,"Tetrahedron Asymmetry","8","23",,"3977","3984",,15,10.1016/S0957-4166(97)00600-9,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031436983&doi=10.1016%2fS0957-4166%2897%2900600-9&partnerID=40&md5=99a8b9593d96fa02c92f13938748b510",Article,Scopus,2-s2.0-0031436983
"Williams, K.M., Turner, J., Geisslinger, G., Day, R.O.","The suction blister as an in vivo model of inflammation: Interblister variability and preliminary studies of the disposition of methotrexate",1997,"Clinical Pharmacology and Therapeutics","61","2",,"160","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33748982698&partnerID=40&md5=d99708635183a03cc1fbd707fea1ae38",Article,Scopus,2-s2.0-33748982698
"Donnelly, R., Williams, K.M., Baker, A.B., Badcock, C.-A., Day, R.O., Seale, J.P.","Effects of budesonide and fluticasone on 24-hour plasma cortisol: A dose-response study",1997,"American Journal of Respiratory and Critical Care Medicine","156","6",,"1746","1751",,64,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031467943&partnerID=40&md5=fb033175608a369f5820eb59ce027a49",Article,Scopus,2-s2.0-0031467943
"Oelkers, R., Neupert, W., Williams, K.M., Brune, K., Geisslinger, G.","Disposition and effects of flurbiprofen enantiomers in human serum and blister fluid",1997,"British Journal of Clinical Pharmacology","43","2",,"145","153",,10,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031059030&partnerID=40&md5=4d6c2cd434320949cce138488c26811f",Article,Scopus,2-s2.0-0031059030
"Simkin, P.A., Bassett, J.E., Lapicque, F., Bertin, P., Netter, P., Day, R.O., Williams, K.M., Geisslinger, G.","Naproxen concentration in plasma and synovial fluid and effects on prostanoid concentrations [1]",1996,"Journal of Rheumatology","23","10",,"1826","1828",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029807198&partnerID=40&md5=b3a07b745510e173b262ee82f7a539a4",Letter,Scopus,2-s2.0-0029807198
"Day, R.O., Francis, H., Vial, J., Geisslinger, G., Williams, K.M.","Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations",1995,"Journal of Rheumatology","22","12",,"2295","2303",,26,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028823462&partnerID=40&md5=df0ba29fffe6456c7078428f5bc01a3c",Article,Scopus,2-s2.0-0028823462
"McLachlan, A.J., Williams, K.M.","Estimation of the rate and extent of chiral inversion using linear systems analysis",1995,"Chirality","7","8",,"632","635",,4,10.1002/chir.530070814,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029559423&doi=10.1002%2fchir.530070814&partnerID=40&md5=b5ae4206a335f547b4fbf0ec04b4f568",Article,Scopus,2-s2.0-0029559423
"Day, R.O., Geisslinger, G., Paull, P., Williams, K.M.","The effect of tenoxicam on tolbutamide pharmacokinetics and glucose concentrations in healthy volunteers",1995,"International Journal of Clinical Pharmacology and Therapeutics","33","5",,"308","310",,5,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029007559&partnerID=40&md5=1e77e4a5d33aede1de74baf9bf6a0eef",Article,Scopus,2-s2.0-0029007559
"Sauernheimer, C., Williams, K.M., Brune, K., Geisslinger, G.","Application of microdialysis to the pharmacokinetics of analgesics: Problems with reduction of dialysis efficiency in vivo",1994,"Journal of Pharmacological and Toxicological Methods","32","3",,"149","154",,34,10.1016/1056-8719(94)90068-X,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028100091&doi=10.1016%2f1056-8719%2894%2990068-X&partnerID=40&md5=2c088148d292cff25fa2819abe3c6747",Article,Scopus,2-s2.0-0028100091
"Schmidt, N., Brune, K., Williams, K.M., Geisslinger, G.","Stereoselective pharmacokinetics of methadone in beagle dogs",1994,"Chirality","6","6",,"492","495",,19,10.1002/chir.530060608,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028129044&doi=10.1002%2fchir.530060608&partnerID=40&md5=1b1487a6d7a87fcc8338cc2e9843ee50",Article,Scopus,2-s2.0-0028129044
"Day, R.O., Brooks, P.M., Williams, K.M., Graham, G.G.","Third World conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992.",1993,"Agents and Actions","38","3-4",,"iv","viii",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027570835&partnerID=40&md5=c22a64bbff8960a3c927b136dd81afb3",Conference Paper,Scopus,2-s2.0-0027570835
"Williams, K.M.","Chiral NSAIDs: So what?",1993,"Agents and Actions","44","SUPPL.",,"15","22",,4,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027179356&partnerID=40&md5=cf51aefcb6ea2cf3df316d7f00bcee28",Conference Paper,Scopus,2-s2.0-0027179356
"Brooks, P.M., Day, R.O., Graham, G.G., Williams, K.M.","Preface",1993,"Agents and Actions","44","SUPPL.",,"","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027202399&partnerID=40&md5=ce3069a1af4111048bcf47d73a27c2b8",Editorial,Scopus,2-s2.0-0027202399
"Williams, K.M., Day, R.O., Breit, S.N.","Biochemical actions and clinical pharmacology of anti-inflammatory drugs",1993,"Advances in Drug Research","24",,,"121","198",,25,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027287784&partnerID=40&md5=4f767713ecf72ffd7ba2dbffff918cf3",Review,Scopus,2-s2.0-0027287784
"Day, R.O., Brooks, P.M., Williams, K.M., Graham, G.G.","Meeting report: Third world conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992",1993,"Agents and Actions","38","3-4",,"","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027270725&partnerID=40&md5=df2ee53c6be444c66e178200a36b0d8d",Conference Paper,Scopus,2-s2.0-0027270725
"Zhao, B., Geisslinger, G., Hall, I., Day, R.O., Williams, K.M.","The effect of the enantiomers of ibuprofen and flurbiprofen on the β‐oxidation of palmitate in the rat",1992,"Chirality","4","3",,"137","141",,31,10.1002/chir.530040302,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026728717&doi=10.1002%2fchir.530040302&partnerID=40&md5=778fd9c687e78bb554c6401e7384bce6",Article,Scopus,2-s2.0-0026728717
"Williams, K.M., Knihinicki, R.D., Day, R.O.","Pharmacokinetics of the enantiomers of ibuprofen in the rabbit",1991,"Agents and Actions","34","3-4",,"381","386",,5,10.1007/BF01988732,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026051719&doi=10.1007%2fBF01988732&partnerID=40&md5=5cc497adaf6cfe3081cb263e776a57db",Article,Scopus,2-s2.0-0026051719
"Knihinicki, R.D., Day, R.O., Williams, K.M.","Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs-II Racemization and hydrolysis of (R)- and (S)-ibuprofen-CoA thioesters",1991,"Biochemical Pharmacology","42","10",,"1905","1911",,60,10.1016/0006-2952(91)90588-V,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025996684&doi=10.1016%2f0006-2952%2891%2990588-V&partnerID=40&md5=b749ae3330bc29511d21feaaa48908b2",Article,Scopus,2-s2.0-0025996684
"Williams, K.M.","Molecular Asymmetry and Its Pharmacological Consequences",1991,"Advances in Pharmacology","22","C",,"57","135",,14,10.1016/S1054-3589(08)60033-2,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026279916&doi=10.1016%2fS1054-3589%2808%2960033-2&partnerID=40&md5=48261251b3870958902e5e58057f5b53",Article,Scopus,2-s2.0-0026279916
"Day, R.O., Williams, K.M., Graham, S., Handel, M.","The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma",1991,"Arthritis &amp; Rheumatism","34","6",,"751","760",,9,10.1002/art.1780340617,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025895927&doi=10.1002%2fart.1780340617&partnerID=40&md5=5df7d312f53663135420c1aa9e8afe42",Article,Scopus,2-s2.0-0025895927
"Lee, E., Williams, K.","Need for precise chiral nomenclature",1990,"Clinical Pharmacokinetics","19","6",,"503","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025695261&partnerID=40&md5=eed7f2641c2ac81b78e71524ce50a16a",Letter,Scopus,2-s2.0-0025695261
"Day, R.O., Walker, J.S., Seideman, P., Knihinicki, R.D., Williams, K.","A human model for evaluation of non-steroidal anti-inflammatory drug (NSAID) distribution into extracellular fluid",1990,"European Journal of Pharmacology","183","3",,"1034","",,,10.1016/0014-2999(90)92891-L,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025111778&doi=10.1016%2f0014-2999%2890%2992891-L&partnerID=40&md5=b598558d6aee907918e9da6e079d87ae",Conference Paper,Scopus,2-s2.0-0025111778
"Nuernberg, B., Knihinicki, R., Williams, K., Freeman, G.E., Dalton, C., Brooks, P.M., Day, R.O.","Anti-inflammatory effects and disposition of S- and R-flurbiprofen in the rat",1990,"European Journal of Pharmacology","183","4",,"1591","1592",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024992822&partnerID=40&md5=5e9c0a189340912c1d2e525d87a2a513",Article,Scopus,2-s2.0-0024992822
"Williams, K.M.","Enantiomers in arthritic disorders",1990,"Pharmacology and Therapeutics","46","2",,"273","295",,67,10.1016/0163-7258(90)90095-J,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025246777&doi=10.1016%2f0163-7258%2890%2990095-J&partnerID=40&md5=406b685f907069e84712cf45e96c1207",Review,Scopus,2-s2.0-0025246777
"Knihinicki, R.D., Day, R.O., Graham, G.G., Williams, K.M.","Stereoselective disposition of ibuprofen and flurbiprofen in rats",1990,"Chirality","2","3",,"134","140",,49,10.1002/chir.530020303,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025165801&doi=10.1002%2fchir.530020303&partnerID=40&md5=f33c9955c9cbc6b9472d0ed791af9ff5",Article,Scopus,2-s2.0-0025165801
"Knihinicki, R.D., Williams, K.M., Day, R.O.","Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs-1. In vitro studies of ibuprofen and flurbiprofen",1989,"Biochemical Pharmacology","38","24",,"4389","4395",,119,10.1016/0006-2952(89)90647-3,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024787109&doi=10.1016%2f0006-2952%2889%2990647-3&partnerID=40&md5=2cf05624cb7a7b23dff7dcb0cd1241fd",Article,Scopus,2-s2.0-0024787109
"Williams, K.M.","CHIRALITY: PHARMACOKINETICS AND PHARMACODYNAMICS IN 3 DIMENSIONS",1989,"Clinical and Experimental Pharmacology and Physiology","16","6",,"465","470",,11,10.1111/j.1440-1681.1989.tb01589.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024395193&doi=10.1111%2fj.1440-1681.1989.tb01589.x&partnerID=40&md5=4e77001ebe389aeddd988cc8cc77dac8",Article,Scopus,2-s2.0-0024395193
"Day, R.O., Williams, K.M., Graham, G.G., Lee, E.J., Knihinicki, R.D., Champion, G.D.","Stereoselective disposition of ibuprofen enantiomers in synovial fluid",1988,"Clinical Pharmacology and Therapeutics","43","5",,"480","487",,61,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023907774&partnerID=40&md5=02037167f287e6b9ac847b7f3b4df797",Article,Scopus,2-s2.0-0023907774
"Williams, K.M., Day, R.O.","The contribution of enantiomers to variability in response to anti-inflammatory drugs.",1988,"Agents and Actions Supplements","24",,,"76","84",,12,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023706490&partnerID=40&md5=72362597cc01d24508bea76837986385",Review,Scopus,2-s2.0-0023706490
"Day, R.O., Graham, G.G., Williams, K.M.","Pharmacokinetics of non-steroidal anti-inflammatory drugs",1988,"Bailliere's Clinical Rheumatology","2","2",,"363","393",,19,10.1016/S0950-3579(88)80019-0,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024224535&doi=10.1016%2fS0950-3579%2888%2980019-0&partnerID=40&md5=a8b25b6ecc47e8c48075fb530a89624c",Article,Scopus,2-s2.0-0024224535
"Day, R.O., Graham, G.G., Williams, K.M., David Champion, G., de Jager, J.","Clinical pharmacology of non-steroidal anti-inflammatory drugs",1987,"Pharmacology and Therapeutics","33","2-3",,"383","433",,78,10.1016/0163-7258(87)90072-6,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023232688&doi=10.1016%2f0163-7258%2887%2990072-6&partnerID=40&md5=adb082712da1d6eb4e40941464be0ec9",Article,Scopus,2-s2.0-0023232688
"Williams, K., Day, R., Knihinicki, R., Duffield, A.","The stereoselective uptake of ibuprofen enantiomers into adipose tissue",1986,"Biochemical Pharmacology","35","19",,"3403","3405",,140,10.1016/0006-2952(86)90443-0,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022498370&doi=10.1016%2f0006-2952%2886%2990443-0&partnerID=40&md5=b39c9b0d310e00e520df4e3497aee3d9",Article,Scopus,2-s2.0-0022498370
"Williams, K.M., Day, R.O.","Stereoselective disposition--basis for variability in response to NSAID's.",1985,"Agents and actions. Supplements","17",,,"119","126",,23,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022294287&partnerID=40&md5=2552725613254a5dee0ec74f3f1a0538",Article,Scopus,2-s2.0-0022294287
"Lee, E., Williams, K., Day, R., Graham, G., Champion, D.","Stereoselective disposition of ibuprofen enantiomers in man.",1985,"British Journal of Clinical Pharmacology","19","5",,"669","674",,237,10.1111/j.1365-2125.1985.tb02694.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022216138&doi=10.1111%2fj.1365-2125.1985.tb02694.x&partnerID=40&md5=0118770064ead600d7208cd5a1cbe810",Article,Scopus,2-s2.0-0022216138
"Williams, K.M.","Kinetics of misonidazole enantiomers",1984,"Clinical Pharmacology and Therapeutics","36","6",,"817","823",,16,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021689746&partnerID=40&md5=3931488667edbd56efbebd190a82b398",Article,Scopus,2-s2.0-0021689746
"Lee, E.J.D., Williams, K.M., Graham, G.G., Day, R.O., Champion, G.D.","Liquid chromatographic determination and plasma concentration profile of optical isomers of ibuprofen in humans",1984,"Journal of Pharmaceutical Sciences","73","11",,"1542","1544",,65,10.1002/jps.2600731112,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021685190&doi=10.1002%2fjps.2600731112&partnerID=40&md5=c3c0355e5d4c1ef1befa76e0295cf763",Article,Scopus,2-s2.0-0021685190
"Williams, K., Begg, E., Wade, D., O'Shea, K.","Effects of phenytoin, phenobarbital, and ascorbic acid on misonidazole elimination",1983,"Clinical Pharmacology and Therapeutics","33","3",,"314","321",,7,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020549106&partnerID=40&md5=8fa539b04ab1848bef8d9906942a8e36",Article,Scopus,2-s2.0-0020549106
"Chinwah, P.M., Williams, K.M., Wade, D.N.","A study of the distribution and elimination of high doses of DPH in rabbits",1982,"Clinical and Experimental Pharmacology and Physiology","9","4",,"459","460",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020364274&partnerID=40&md5=5b7f76b55e8b65cb10e704157640b794",Article,Scopus,2-s2.0-0020364274
"Williams, K.M., Begg, E.J., Wade, D.N., O'Shea, K.","The effect of phenytoin, phenobarbitone and ascorbic acid on the elimination of misonidazole (Ro 07-0582) in man",1982,"Clinical and Experimental Pharmacology and Physiology","9","4",,"423","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020422442&partnerID=40&md5=dfc9e94ff35fa01043e1898636ac444a",Article,Scopus,2-s2.0-0020422442
"Tung, C., Graham, G.G., Wade, D.N., Williams, K.M.","The pharmacokinetics of chlorbutol in man",1982,"Biopharmaceutics &amp; Drug Disposition","3","4",,"371","378",,11,10.1002/bdd.2510030410,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020427065&doi=10.1002%2fbdd.2510030410&partnerID=40&md5=857ab4cfb794464ecccb3e038898bb6a",Article,Scopus,2-s2.0-0020427065
"Chinwah, P.M., Wade, D.N., Williams, K.M.","Phenytoin, phenobarbitone and carbamazepine elimination kinetics in overdosed patients",1981,"Clinical and Experimental Pharmacology and Physiology","8","6",,"","",,1,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019833975&partnerID=40&md5=6c28609a6853286ea6710bf0f3eba1f6",Article,Scopus,2-s2.0-0019833975
"Williams, K.M., Duffield, A.M., Christopher, R.K., Finlayson, P.J.","Identification of minor metabolites of 5‐fluorocytosine in man by chemical ionization gas chromatography mass spectrometry",1981,"Biological Mass Spectrometry","8","4",,"179","182",,16,10.1002/bms.1200080410,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019870367&doi=10.1002%2fbms.1200080410&partnerID=40&md5=3e12233b428dc7485d4b3e636ed54b17",Article,Scopus,2-s2.0-0019870367
"Tung, C., Graham, G.G., Wade, D.N., Williams, K.M.","The pharmacokinetics of chlorbutol",1980,"Clinical and Experimental Pharmacology and Physiology","7","6",,"672","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019186558&partnerID=40&md5=6f0dffc5258625fd50648230daca97e7",Article,Scopus,2-s2.0-0019186558
"Williams, K.M., Duffield, A.M., Christopher, R.K., Finlayson, P.J.","Minor metabolites of 5-fluorocytosine in man",1980,"Clinical and Experimental Pharmacology and Physiology","7","6",,"681","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019200084&partnerID=40&md5=249b8a3c38b806744b1bb3c1bc7dc66a",Article,Scopus,2-s2.0-0019200084
"Chinwah, P., Williams, K.","Comparison of enzyme immunoassay for gentamicin compared with other methods",1980,"Journal of Antimicrobial Chemotherapy","6","4",,"561","562",,,10.1093/jac/6.4.561,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019199512&doi=10.1093%2fjac%2f6.4.561&partnerID=40&md5=c7d643e038b5225cc6800780de5a4327",Letter,Scopus,2-s2.0-0019199512
"Williams, K.M., Wade, D.N.","Drug assay services and therapeutic drug use in a general hospital",1980,"Medical Journal of Australia","1","9",,"444","446",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0018891871&partnerID=40&md5=d3dbdc4fd742fd26b6c804a368ceb25f",Article,Scopus,2-s2.0-0018891871
"Williams, K.M., Chinwah, P.M., Cobcroft, R.","Crystalluria during flucytosine therapy",1979,"Medical Journal of Australia","2","11",,"617","",,4,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0018632794&partnerID=40&md5=4186314cbaf885a0226638ea6100d8aa",Article,Scopus,2-s2.0-0018632794
"Borody, T., Chinwah, P.M., Graham, G.G., Wade, D.N., Williams, K.M.","Chlorbutol toxicity and dependence",1979,"Medical Journal of Australia","1","7",,"288","",,13,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0018757485&partnerID=40&md5=17898b94b55888925cf352a805b53612",Article,Scopus,2-s2.0-0018757485
